
Proactive Investors: Your Source for Professional, Educated, and Profit-Focused News
GSK PLC Receives FDA Approval for Meningitis Vaccine Introduction GSK PLC has recently received approval from the US Food and Drug Administration for its Penmenvy meningitis vaccine. This vaccine is designed to target five major serogroups of meningitis-causing Neisseria meningitidis bacteria. According to GSK, the vaccine has been approved for individuals between the ages of…